Navigation Links
Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
Date:12/16/2011

BETHLEHEM, Pa., Dec. 16, 2011 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, today announced it has entered into distribution agreements with Genoxa of Puck, Poland and AB ANALITICA of Padua, Italy, for My5-FU™, a test that measures levels of a widely-used anti-cancer drug, 5-fluorouracil (5-FU), in the blood of cancer patients. 

"Our new partnership with AB ANALITICA and Genoxa continues the expansion of our marketing and distribution channels in Europe, which will facilitate adoption of 5-FU dose management in these new markets for Saladax," said Adrienne Choma, Esq., senior vice president and Chief Marketing Officer of Saladax.

Genoxa will be the exclusive provider of My5-FU testing services to oncologists in Poland, enabling them to individualize the dose of 5-FU to optimize therapeutic efficacy and reduce toxicity for their patients.  Genoxa is a privately owned clinical reference laboratory focused on providing personalized medicine testing services.  "We are pleased to introduce this exciting new technology from Saladax to the Polish oncology community and offer cancer patients better treatment options," commented Artur Wilandt, co-founder and CEO of Genoxa.

In Italy, AB ANALITICA will be the exclusive distributor of My5-FU testing kits to hospital and reference laboratories.  Mikkel Johansen, marketing manager for AB ANALITICA, said, "We are delighted with our partnership with Saladax.  The addition of My5-FU fits nicely into our current portfolio of diagnostic tests."  AB ANALITICA is focused on the development and commercialization of diagnostic tests for human infectious diseases, oncology, genetic diseases, target therapies and pharmacogenetics. 

About My5-FU
Saladax's first commercially available test for in
'/>"/>

SOURCE Saladax Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
2. Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey
3. Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital
4. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
5. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
6. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
7. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
8. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
9. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
10. Sony Expands Radiology Product Offerings with Full Line of Diagnostic Displays
11. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 30, 2015 Mordor Intelligence presents ... Primary Packaging Material (Plastic, Glass, Paper, Metal) - ByType of ... Pouches, Syringes, Tubes, Vials, Sachets) - By Geographical Region ( ... Asia Pacific , Latin America ... Africa ) - discussing Industry Value Chain Analysis, ...
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... June 21, 2011 Enox Biopharma, Inc. CEO, John C. ... Innovation Conference on Wednesday, June 22 at 12:15 AM EST. ... in Boston. The IN3 East meeting, hosted ... The meeting is designed to provide exposure and constructive interaction ...
... MOUNT LAUREL, N.J., June 21, 2011 ImpactRx, ... on physician prescribing behavior announced that Kjell Nygren, ... Analytical Services.  Kjell will strengthen the company,s position ... address clients, needs for better understanding the effectiveness ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2ImpactRx Names Kjell Nygren Vice President, Analytical Services 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... Rehab”. The video focuses on the rehab center’s patients and their experiences at ... the best quality of services available. Each patient attests to the high rating, ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June 15th report ... study how sensory stimuli can be used to “decrease children’s anxiety and negative responses ... with autism, will compare patient experience in a “typical dental environment” with one that ...
(Date:6/30/2015)... Long Beach, CA (PRWEB) , ... June 30, 2015 , ... ... Sea Skilled Nursing”, which features multiple patient and family member testimonials. Medicare rated the ... the country. Broadway plans to use the video to give future patients a firsthand ...
(Date:6/30/2015)... New York, NY (PRWEB) , ... June 30, ... ... international shipping when buying eyeglasses online , finally its here, ... and offer express shipping rates, for many location, ask about shipping with DHL ...
(Date:6/30/2015)... New York (PRWEB) , ... June 30, 2015 ... ... ( http://www.xareltolawsuit2015.com/ ) currently pending in a federal multidistrict litigation now underway in ... Court convenes its next monthly Status Conference. According to the Court’s calendar, that ...
Breaking Medicine News(10 mins):Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3
... the cost of such tests is a potential stumbling block, ... the heart arteries for calcium deposits can help predict future ... that adding such scans to routine checkups would be worth ... of potential heart trouble, said Dr. Diane Bild, deputy director ...
... Michael D. Farley has,joined the Lupus ... Washington,DC as the organization,s Chief Operating Officer, ... overall organizational administration and,field development. Farley has ... including serving most recently as the,interim CEO ...
... Inc.,(Nasdaq: EMAG ), a leader in ... healthcare networks, announced today that its,HeartSuite(TM) VERICIS(R) ... for,Cardiology PACS*. HeartSuite is Emageon,s comprehensive suite ... information,management, hemodynamic monitoring, advanced visualization and content,management. ...
... PURCELLVILLE, Va., March 26 At a panel,discussion ... Force Colonel,Mike Turner, a candidate for U.S. Congress ... for Professor Judy Feder, his opponent,in the June ... Frank,Wolf in what is expected to be a ...
... Courses Improve Patient Care and Address State Regulations, ... Care Compliance,Strategies, Inc.), the leading provider of online ... with University,HealthSystem Consortium (UHC) to deliver a suite ... 11 courses with multimedia content and,healthcare specific case ...
... of Other Medicare Providers at Risk, WASHINGTON, ... drug plans (PDPs) pay drugstores twice as fast,as ... and its,beneficiaries at least $3.3 billion over the ... (PwC) that was commissioned by the,Pharmaceutical Care Management ...
Cached Medicine News:Health News:Calcium Scans Help Predict Coronary Risk 2Health News:Michael D. Farley Appointed Chief Operating Officer of Lupus Foundation of America, Inc. 2Health News:Emageon Receives 'Best in KLAS' Cardiology PACS Award 2Health News:Democrat Mike Turner Backs Single-Payer Healthcare; Opponent Feder Undecided 2Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 2Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 3
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine....
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma...
For the quantitative in vitro determination of Triglycerides in serum and plasma....
Medicine Products: